Taiko Pharmaceutical Co.,Ltd. provided earnings guidance for the year ending December 2023. For the year, the company's net sales to be ¥6,400 million, operating profit to be ¥(800)million, net income to be ¥(950) million or Basic earnings per share to be ¥(20.42).
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
485 JPY | +4.53% |
|
+9.26% | +59.74% |
1st Jan change | Capi. | |
---|---|---|
+59.74% | 152M | |
+25.40% | 45.54B | |
+37.85% | 24.51B | |
+27.12% | 16.48B | |
+21.19% | 14.66B | |
+71.91% | 14.3B | |
-0.05% | 6.79B | |
-11.23% | 6.73B | |
+15.08% | 5.87B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- 4574 Stock
- News Taiko Pharmaceutical Co.,Ltd.
- Taiko Pharmaceutical Co.,Ltd. Provides Earnings Guidance for the Year Ending December 2023